June 10, 2010
PAI partners agrees to acquire a majority interest in French clinical pathology business Cerba European Lab (CEL) from IK Investment Partners.
On June 9, it was announced that Willkie client PAI partners agreed to acquire a majority interest in French clinical pathology business Cerba European Lab (CEL) from IK Investment Partners (formerly known as Industri Kapital). CEL operates in 34 locations across Europe, the United States, South Africa, Australia and China. With 2010 consolidated sales estimated at €250 million, CEL has a staff of over 1,300 employees and performs 85,000 tests daily. PAI partners is one of the oldest and most experienced private equity firms in Europe.
The Willkie deal team, led by partner Eduardo Fernandez, included partners Daniel Payan and Jacques-Philippe Gunther; National Partner Charlotte Breuvart; and associates Karine Lenczner, Brice Voillequin, Philippe Bugnazet, Audrey Levy-Corcos, Vanessa Zecchinel and Sylviane Bartholomeeusen.
